○Kentaro Tanaka (Research Institute for Disease of the Chest, Graduate School of Medical Sciences, Kyushu University)
Session information
Morning Seminar
[MoS03] Morning Seminar 3 Imfinzi: aiming for long-term survival and cure ~Latest clinical trials data in NSCLC and SCLC~
Fri. Feb 18, 2022 7:20 AM - 8:10 AM Room 4 (Room A, 2F, Kyoto International Conference Center)
Chair:Toshiaki Takahashi(Division of Thoracic Oncology, Shizuoka Cancer Center)
Sponsored by AstraZeneca K.K.
○Hiroyasu Kaneda (Department of Clinical Oncology, Graduate School of Medicine, Osaka City University)